Filing Flows › Edwards Lifesciences (EW) › R&D spending
Edwards Lifesciences (EW) R&D spending by quarter
Edwards Lifesciences' R&D spending was $281M in Q3 2026 (third quarter 2026), +7% from Q1 2026. Over the last 5 quarters it ranged from $263M (Q1 2026) to $281M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $281M | +7% | +0.2% |
| Q1 2026 | $263M | -2% | — |
| Q4 2025 | $268M | -5% | — |
| Q3 2025 | $281M | +2% | — |
| Q2 2025 | $276M | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' R&D spending?
Edwards Lifesciences' R&D spending was $281M in Q3 2026 (third quarter 2026), +7% from Q1 2026.
How has Edwards Lifesciences' R&D spending changed?
Over the last 5 quarters it ranged from $263M (Q1 2026) to $281M (Q3 2026).